Vildagliptin CLAF237A23104 - Multicenter, double-blind, randomized parallel- group study, demonstrate the effect of 24 weeks treatment with vildagliptin 100 mg add-on to metformin 500 mg - 1000 mg, patients with typ 2 diabetes.
Laufzeit: 01.01.2007 - 31.12.2009